APA (7th ed.) Citation

R, G., KY, L., T, N., JS, L., & WL, K. (2022). Combinatorial Treatment with PARP-1 Inhibitors and Cisplatin Attenuates Cervical Cancer Growth through Fos-Driven Changes in Gene Expression. Molecular cancer research : MCR, 20(8), 1183. https://doi.org/10.1158/1541-7786.MCR-22-0111

Chicago Style (17th ed.) Citation

R, Gupte, Lin KY, Nandu T, Lea JS, and Kraus WL. "Combinatorial Treatment with PARP-1 Inhibitors and Cisplatin Attenuates Cervical Cancer Growth Through Fos-Driven Changes in Gene Expression." Molecular Cancer Research : MCR 20, no. 8 (2022): 1183. https://doi.org/10.1158/1541-7786.MCR-22-0111.

MLA (9th ed.) Citation

R, Gupte, et al. "Combinatorial Treatment with PARP-1 Inhibitors and Cisplatin Attenuates Cervical Cancer Growth Through Fos-Driven Changes in Gene Expression." Molecular Cancer Research : MCR, vol. 20, no. 8, 2022, p. 1183, https://doi.org/10.1158/1541-7786.MCR-22-0111.